Aligos Therapeutics

Aligos Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted therapies for metabolic dysfunction associated steatohepatitis (MASH) and viral diseases, including chronic hepatitis B (CHB) and coronavirus. Their mission is to become a global leader in this field by leveraging their expertise in small molecule and oligonucleotide platforms to identify and develop potentially best-in-class drug candidates.

Aligos prioritizes a science-first, data-driven culture, fostering a highly collaborative and fast-paced environment where employees are encouraged to contribute and take ownership. This commitment extends to their generous benefits package and hybrid work philosophy, ensuring a supportive and dynamic work experience for their employees.

Aligos Therapeutics embraces a hybrid work philosophy, prioritizing in-person collaboration while offering flexibility for remote work options. The company recognizes the value of face-to-face interaction and has implemented robust health and safety protocols to support this. However, they empower team leaders to determine the best working arrangements for their teams, offering flexibility and adjusting their philosophy based on evolving workplace mandates and employee needs.

Aligos Therapeutics offers a comprehensive benefits package to its employees, including health insurance with medical, dental, and vision coverage in the US, as well as life, short and long-term disability insurance. In the EU, they provide hospitalization insurance. Employees also benefit from generous time off policies with paid holidays, year-end holiday closure, paid time off, paid sick leave, and new parent leave. Financially, they offer a 401(k) with employer match in the US, and pension plan support in the EU. Employees also have access to an Employee Stock Purchase Plan and equity compensation. Other perks include transit and parking FSA in the US, a company car for eligible employees in the EU, career development opportunities, meal subsidy, and a dog-friendly workplace in the US.

Aligos Therapeutics is a clinical-stage biopharmaceutical company dedicated to becoming a world leader in developing targeted therapies for metabolic dysfunction-associated steatohepatitis (MASH) and viral diseases. Driven by a commitment to addressing unmet medical needs, Aligos leverages its small molecule and oligonucleotide platforms to identify drug candidates with clinically validated targets and pharmacologically optimized characteristics. This approach aims to deliver transformative treatment options for patients facing these complex conditions.

Aligos Therapeutics fosters a collaborative and fast-paced environment that values science, data, and its employees. They promote diversity and inclusion, encourage initiative and ownership, and support individual growth through mentorship and professional development opportunities. Their culture is dynamic and accountable, emphasizing efficiency and high-quality results while maintaining a supportive atmosphere that encourages employees to strive for success.

Aligos Therapeutics values a diverse and inclusive workplace, actively seeking talent from various backgrounds and experiences. They champion diversity, equity, and inclusion in their initiatives, empowering employees to take ownership of projects and fostering a supportive environment through mentorship and professional development opportunities.